Mahdi Rezaei

The point is that dyspnea relief can be treated as its own therapeutic target separate from simply chasing oxygen numbers.

A twenty twenty-five study titled "Comparison of the Effects of Inhalant Furosemide, Oxygen Therapy, and Placebo in Patients with Acute Dyspnea Referred to Emergency Departments by EMS in Various Hospitals in Tehran" by Mahdi Rezaei et al.

evaluated acute dyspnea treatment in people aged eighteen to seventy-five years.

Patients received nebulized furosemide, oxygen, or placebo in the pre-hospital setting.